Skip to main content
Veterinary Medicines

HIPPOMECTIN 12 mg/g oral gel for horses

Not authorised
  • Ivermectin

Product identification

Medicine name:
HIPPOMECTIN 12 mg/g oral gel for horses
HIPPOMECTIN 12 MG/G GEL ORAL POUR CHEVAUX
Active substance:
  • Ivermectin
Target species:
  • Horse
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Ivermectin
    12.00
    milligram(s)
    /
    1.00
    gram(s)
Pharmaceutical form:
  • Oral gel
Withdrawal period by route of administration:
  • Oral use
    • Horse
      • Meat and offal
        18
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP54AA01
Authorisation status:
  • Surrendered
Authorised in:
  • France
Package description:
  • 13.3 g pre-filled multi-dose (LDPE) syringe with adjustable screw ring closed with a (PE) cap, packed in a cardboard box.
  • 10 g pre-filled multi-dose (LDPE) syringe with adjustable screw ring closed with a (PE) cap, packed in a cardboard box.

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Le Vet. B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Produlab Pharma B.V.
Responsible authority:
  • French Agency For Food, Environmental And Occupational Health & Safety
Authorisation number:
  • FR/V/2010798 5/2008
Date of authorisation status change:
Reference member state:
  • Netherlands
Procedure number:
  • NL/V/0132/001

Documents

Combined File of all Documents

English (PDF)
Published on: 7/06/2022
Download

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 4/04/2022
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."